| Financial Year |
March 31 2023 |
| Monetary Funds |
15,331,384,296.63 |
| Held-for-trading Financial Assets |
1,046,950,573.99 |
| Notes Receivable |
1,534,170,019.88 |
| Accounts Receivable |
11,733,522,073.45 |
| Advances to Suppliers |
5,813,625,450.94 |
| Other Receivables |
660,327,634.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
74,222,183.04 |
| Dividend Receivable |
32,671,545.51 |
| Inventories |
18,965,450,311.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
759,472,409.17 |
| Other Current Assets |
859,625,103.17 |
| Total Current Assets |
72,025,811,370.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
164,993,005.60 |
| Long-term Equity Investment |
2,526,719,979.76 |
| Investment Properties |
149,500,754.23 |
| Fixed Assetes |
4,861,720,899.08 |
| Under-construction Projects |
402,354,261.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,748,491,884.88 |
| R&D expenses |
21,468,063.13 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,978,198.81 |
| Deferred Income Tax Assets |
3,148,542,875.85 |
| Other Non-Current Assets |
4,546,428,285.01 |
| Sub-Total of Non-Current Assets |
46,471,959,126.22 |
| Total Assets |
118,497,770,496.88 |
| Short-Term Loans |
124,671,155.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
12,059,870,412.48 |
| Accounts Payable |
20,379,275,648.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
741,669,193.38 |
| Taxes Payable |
344,059,495.48 |
| Interest Payable |
7,872,633.06 |
| Dividend Payable |
12,212,826.57 |
| Other payables |
1,329,817,061.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
626,139,551.90 |
| Other Current Liabilities |
266,869,782.27 |
| Sub-Total of Current Liabilities |
69,615,117,678.70 |
| Long-term Loans |
965,276,867.51 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
240,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
6,457,047,084.57 |
| Deferred Income Tax Liabilities |
61,991,645.61 |
| Other Non-Current Liabilities |
3,716,013.93 |
| Sub-Total of Non-Current Liabilities |
9,159,341,190.61 |
| Total Liabilities |
78,774,458,869.31 |
| Paid-In Capital(Or Share Stock) |
3,118,533,797.00 |
| Capital Surplus |
11,643,774,311.11 |
| Surplus Reserve |
1,201,503,540.86 |
| LESS:Treasury Stock |
111,093,911.81 |
| Undistributed Profits |
20,018,117,827.22 |
| Minority Stockholder's Interest |
3,709,651,589.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
36,013,660,038.48 |
| Owner's Equity（Stockholder's Equity） |
39,723,311,627.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
118,497,770,496.88 |
